Alopecia Clinical Trials in Minneapolis, Minnesota
5 recruitingMinneapolis, Minnesota
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
AlopeciaSkin DiseasesAreata Alopecia+3 more
Eli Lilly and Company595 enrolled127 locationsNCT05723198
Recruiting
Phase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
AbbVie1,500 enrolled268 locationsNCT06012240
Recruiting
Phase 3
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
Severe Alopecia Areata
Pfizer225 enrolled80 locationsNCT07029711
Recruiting
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Alopecia Areata
Pfizer850 enrolled58 locationsNCT06531109
Recruiting
Phase 2
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Alopecia AreataAlopecia TotalisAlopecia Universalis
University of Minnesota40 enrolled1 locationNCT06747611